Human Gene MIR34B (ENST00000385076.3) from GENCODE V44
  Description: Homo sapiens microRNA 34b (MIR34B), microRNA. (from RefSeq NR_029839)
RefSeq Summary (NR_029839): microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]. Sequence Note: This record represents a predicted microRNA stem-loop as defined by miRBase. Some sequence at the 5' and 3' ends may not be included in the intermediate precursor miRNA produced by Drosha cleavage.
Gencode Transcript: ENST00000385076.3
Gencode Gene: ENSG00000207811.3
Transcript (Including UTRs)
   Position: hg38 chr11:111,512,938-111,513,021 Size: 84 Total Exon Count: 1 Strand: +


Page IndexSequence and LinksPrimersCTDRNA-Seq ExpressionMicroarray Expression
Other SpeciesmRNA DescriptionsOther NamesMethods
Data last updated at UCSC: 2023-08-18 00:09:47

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr11:111,512,938-111,513,021)mRNA (may differ from genome)No protein
Gene SorterGenome BrowserOther Species FASTAGene interactionsTable SchemaBioGPS
EnsemblEntrez GeneExonPrimerGencodeHGNCLynx
MalacardsOMIMPubMedBioGrid CRISPR DB

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 0.00 RPKM in Adipose - Subcutaneous
Total median expression: 0.00 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
      
      
      
      
      

-  Descriptions from all associated GenBank mRNAs
  JD024317 - Sequence 5341 from Patent EP1572962.
CS266367 - Sequence 59 from Patent WO2005118806.
DL076529 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004179 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FU261116 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763618 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FW421521 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FW504785 - COMPOSITIONS COMPRISING MIR34 THERAPEUTIC AGENTS FOR TREATING CANCER.
HI508136 - Sequence 5 from Patent EP2152722.
HV304517 - JP 2009531018-A/84: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305015 - JP 2009531019-A/84: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV444479 - JP 2011515078-A/11: TREATMENT, DIAGNOSTIC, AND METHOD FOR DISCOVERING ANTAGONIST USING SPARC SPECIFIC MIRNAS.
HV753790 - JP 2012509675-A/28: COMPOSITIONS AND METHODS FOR DETECTING SMALL RNAS, AND USES THEREOF.
HW102016 - JP 2013500034-A/143: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW119224 - JP 2013046612-A/84: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW367392 - JP 2012228254-A/59: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW411785 - JP 2014000079-A/59: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW505122 - JP 2014502606-A/24: MELANOMA TREATMENTS.
HW589553 - JP 2013121348-A/84: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW674131 - JP 2014217381-A/59: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ043220 - JP 2015510401-A/310: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ067073 - JP 2014012020-A/59: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ081846 - JP 2015514392-A/310: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ408234 - JP 2015528002-A/831: CHIRAL CONTROL.
HZ413357 - JP 2014060993-A/84: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ427497 - JP 2014217384-A/59: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428300 - JP 2014217385-A/59: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429103 - JP 2014217386-A/59: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429906 - JP 2014217387-A/59: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ501568 - JP 2016025853-A/84: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ769163 - JP 2014223080-A/59: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058557 - Sequence 59 from Patent EP2298893.
JA059360 - Sequence 59 from Patent EP2298894.
JA073683 - Sequence 59 from Patent EP2281887.
JA104820 - Sequence 59 from Patent EP2302051.
JA106160 - Sequence 59 from Patent EP2302052.
JA106963 - Sequence 59 from Patent EP2302053.
JA107766 - Sequence 59 from Patent EP2302054.
JA108569 - Sequence 59 from Patent EP2302055.
JA109372 - Sequence 59 from Patent EP2302056.
JA191888 - Sequence 59 from Patent EP2290066.
JA192787 - Sequence 59 from Patent EP2290067.
JA193686 - Sequence 59 from Patent EP2290068.
JA194585 - Sequence 59 from Patent EP2290069.
JA195484 - Sequence 59 from Patent EP2290070.
JA196383 - Sequence 59 from Patent EP2290071.
JA197282 - Sequence 59 from Patent EP2290072.
JA198181 - Sequence 59 from Patent EP2290073.
JA199080 - Sequence 59 from Patent EP2290074.
JA199979 - Sequence 59 from Patent EP2290075.
JA200878 - Sequence 59 from Patent EP2290076.
JA218000 - Sequence 59 from Patent EP2281888.
JA226151 - Sequence 59 from Patent EP2292755.
JA229006 - Sequence 59 from Patent EP2292756.
JA257277 - Sequence 59 from Patent EP2284265.
JA278557 - Sequence 59 from Patent EP2281886.
JA284443 - Sequence 59 from Patent EP2281889.
JA292496 - Sequence 59 from Patent EP2287303.
JA317682 - Sequence 59 from Patent EP2314688.
JA374741 - Sequence 59 from Patent EP2322616.
JA525934 - Sequence 84 from Patent EP2369011.
JA526441 - Sequence 84 from Patent EP2369012.
JA526948 - Sequence 84 from Patent EP2369013.
JA535877 - Sequence 84 from Patent EP2371971.
JA787882 - Sequence 84 from Patent EP2479285.
JA788380 - Sequence 84 from Patent EP2479286.
JA810714 - Sequence 84 from Patent EP2468890.
JA811212 - Sequence 84 from Patent EP2468891.
JA811710 - Sequence 84 from Patent EP2468893.
JA812208 - Sequence 84 from Patent EP2468894.
JA812706 - Sequence 84 from Patent EP2468895.
JA813204 - Sequence 84 from Patent EP2468896.
JA813702 - Sequence 84 from Patent EP2468897.
JA814200 - Sequence 84 from Patent EP2468898.
JA814698 - Sequence 84 from Patent EP2468899.
JA816941 - Sequence 84 from Patent EP2468892.
JA825753 - Sequence 84 from Patent EP2471956.
JA826251 - Sequence 84 from Patent EP2471958.
JB024538 - Sequence 84 from Patent EP2505668.
JB025036 - Sequence 84 from Patent EP2505669.
JB037923 - Sequence 39 from Patent WO2012107841.
JB079423 - Sequence 84 from Patent EP2487252.
JB079921 - Sequence 84 from Patent EP2487253.
JB080419 - Sequence 84 from Patent EP2487254.
JB080917 - Sequence 84 from Patent EP2487255.
JB081415 - Sequence 84 from Patent EP2487256.
JB081913 - Sequence 84 from Patent EP2487257.
JB082411 - Sequence 84 from Patent EP2487258.
JB082909 - Sequence 84 from Patent EP2487259.
JB083407 - Sequence 84 from Patent EP2487260.
JB083905 - Sequence 84 from Patent EP2487261.
JB084403 - Sequence 84 from Patent EP2487262.
JB084901 - Sequence 84 from Patent EP2487263.
JB087579 - Sequence 84 from Patent EP2502630.
JB147783 - Sequence 84 from Patent EP2484782.
JB148281 - Sequence 84 from Patent EP2484783.
JB153006 - Sequence 84 from Patent EP2514433.
JB153504 - Sequence 84 from Patent EP2514434.
JB622093 - Sequence 84 from Patent EP2586454.
JB622591 - Sequence 84 from Patent EP2586455.
JC001654 - Sequence 84 from Patent EP2591794.
JC221584 - Sequence 59 from Patent EP2471923.
JC268150 - Sequence 59 from Patent EP2471924.
JC340458 - Sequence 59 from Patent EP2471922.
JC469704 - Sequence 59 from Patent EP2471921.
JC572001 - Sequence 15 from Patent EP2759595.
JC990493 - Sequence 59 from Patent EP2808390.
JD020155 - Sequence 1179 from Patent EP1572962.
LF132450 - JP 2016506923-A/15: Composition comprising an encapsulated antagomir.
LF404317 - JP 2015509366-A/310: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LF714596 - JP 2016165292-A/59: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856530 - JP 2015142597-A/59: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
LG051568 - KR 1020150036642-A/834: CHIRAL CONTROL.
LG162314 - KR 1020160018451-A/15: Composition comprising an encapsulated antagomir.
LQ101334 - Sequence 39 from Patent WO2015101653.
LQ276049 - Sequence 39 from Patent WO2016071729.
MA259142 - JP 2017502699-A/39: LUNG CANCER DETERMINATIONS USING MIRNA RATIOS.
MA353848 - JP 2018075017-A/310: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
MP045488 - Sequence 310 from Patent EP3401394.
MP084158 - Sequence 310 from Patent EP3401393.
FZ421158 - JP 2010539978-A/58: INCREASING ERYTHROPOIETIN USING NUCLEIC ACIDS HYBRIDIZABLE TO MICRO-RNA AND PRECURSORS THEREOF.
HW502472 - JP 2014050389-A/58: INCREASING ERYTHROPOIETIN USING NUCLEIC ACIDS HYBRIDIZABLE TO MICRO-RNA AND PRECURSORS THEREOF.
CS548418 - Sequence 1448 from Patent EP1777301.
FU757830 - Method for detection of cancer.
FV524041 - Diagnosis and therapeutic choice of gynecologic cancer using micro RNA as biomarker.
FW312160 - DETECTING NUCLEIC ACIDS.
FW364247 - Oligonucleotides for modulating target RNA activity.
FW393830 - Diagnosis and therapeutic choice of gynecologic cancer using micro RNA as biomarker.
HI965150 - Sequence 435 from Patent WO2010139812.
HI966325 - Sequence 645 from Patent WO2010139811.
HI967191 - Sequence 645 from Patent WO2010139810.
HV036072 - WO 2011027893-A/3: A method for predicting the efficacy of chronic hepatitis C treatment.
HV534433 - WO 2011111715-A/949: Nucleic acid for controlling cell cycle.
HV595156 - JP 2010539959-A/537: Micromirs.
HV753792 - JP 2012509675-A/30: COMPOSITIONS AND METHODS FOR DETECTING SMALL RNAS, AND USES THEREOF.
HW101964 - JP 2013500034-A/91: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW505491 - JP 2014502606-A/393: MELANOMA TREATMENTS.
HW612384 - JP 2014140377-A/2: Method for detection of cancer.
HW906897 - WO 2015037656-A/112: Autophagy-regulating microRNA.
HZ043111 - JP 2015510401-A/201: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ074162 - JP 2013535982-A/253: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ081737 - JP 2015514392-A/201: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ157713 - JP 2015130862-A/537: Micromirs.
HZ186560 - JP 2015146814-A/309: Oligonucleotides for modulating target RNA activity.
HZ466306 - JP 2015531594-A/9: METHODS OF GENERATING MESENCHYMAL STEM CELLS WHICH SECRETE NEUROTROPHIC FACTORS.
HZ480237 - JP 2015535430-A/743: TERMINALLY MODIFIED RNA.
HZ790168 - JP 2016504050-A/1913: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA287409 - Sequence 91 from Patent WO2011015720.
JA401188 - Sequence 435 from Patent WO2011080318.
JA402166 - Sequence 435 from Patent WO2011080315.
JA403173 - Sequence 435 from Patent WO2011080316.
JA405804 - Sequence 435 from Patent EP2336353.
JA427082 - Sequence 415 from Patent WO2011072177.
JA429330 - Sequence 435 from Patent WO2011095623.
JA660659 - Sequence 113 from Patent WO2011131354.
JA757965 - Sequence 98 from Patent WO2012010584.
JB022815 - Sequence 69 from Patent WO2013026684.
JB037924 - Sequence 40 from Patent WO2012107841.
JB136693 - Sequence 3 from Patent EP2476758.
JB620063 - Sequence 43 from Patent WO2013063544.
JB620338 - Sequence 318 from Patent WO2013063544.
JC265632 - Sequence 2 from Patent WO2013017542.
JC334247 - Sequence 165 from Patent EP2487240.
JC512900 - Sequence 3153 from Patent WO2014113089.
JC572034 - Sequence 48 from Patent EP2759595.
JE869361 - Sequence 2 from Patent WO2015131115.
JE978668 - Sequence 113 from Patent EP2865765.
LF132483 - JP 2016506923-A/48: Composition comprising an encapsulated antagomir.
LF159955 - JP 2016513950-A/21: Oligomers with improved off-target profile.
LF404208 - JP 2015509366-A/201: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LF636393 - JP 2016519076-A/167: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS.
LF838609 - JP 2016530232-A/4: Biomarkers of miR-34 Activity.
LG134550 - KR 1020150131312-A/168: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS.
LG162347 - KR 1020160018451-A/48: Composition comprising an encapsulated antagomir.
LP636952 - Sequence 2 from Patent EP2848702.
LP726951 - Sequence 645 from Patent EP2883966.
LP819221 - Sequence 645 from Patent EP3296406.
LP939163 - Sequence 645 from Patent EP3184651.
LP997075 - Sequence 24 from Patent WO2017136662.
LQ069374 - Sequence 2 from Patent WO2015153757.
LQ070488 - Sequence 812 from Patent EP2964234.
LQ101335 - Sequence 40 from Patent WO2015101653.
LQ276050 - Sequence 40 from Patent WO2016071729.
LQ417676 - Sequence 12 from Patent WO2016125163.
LY405221 - KR 1020160117535-A/526: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LY409557 - KR 1020160122850-A/2: SORAFENIB-MICRORNA COMBINATION THERAPY FOR LIVER CANCER.
LZ233917 - JP 2017184756-A/309: Oligonucleotides for modulating target RNA activity.
LZ986416 - JP 2017225396-A/18: Complex and use thereof.
LZ991537 - WO 2017221875-A/18: COMPLEX AND USE THEREOF.
MA259143 - JP 2017502699-A/40: LUNG CANCER DETERMINATIONS USING MIRNA RATIOS.
MA260460 - JP 2017505623-A/526: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA264539 - JP 2017507955-A/2: SORAFENIB-MICRORNA COMBINATION THERAPY FOR LIVER CANCER.
MA353739 - JP 2018075017-A/201: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
MA625403 - JP 2018138044-A/9: METHODS OF GENERATING MESENCHYMAL STEM CELLS WHICH SECRETE NEUROTROPHIC FACTORS.
MA643989 - JP 2017113010-A/1913: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731873 - JP 2017140048-A/743: TERMINALLY MODIFIED RNA.
MP029287 - Sequence 9 from Patent WO2018219998.
MP045379 - Sequence 201 from Patent EP3401394.
MP073577 - Sequence 24 from Patent WO2018236590.
MP075718 - Sequence 57 from Patent WO2019002265.
MP080350 - Sequence 24 from Patent WO2018236589.
MP084049 - Sequence 201 from Patent EP3401393.
MS673266 - Sequence 69 from Patent EP3135774.
MS834289 - Sequence 435 from Patent EP3112479.
DQ601590 - Homo sapiens piRNA piR-39656, complete sequence.
DQ592638 - Homo sapiens piRNA piR-59750, complete sequence.
DJ003843 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
DJ027122 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
FU261389 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763891 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FW504784 - COMPOSITIONS COMPRISING MIR34 THERAPEUTIC AGENTS FOR TREATING CANCER.
HH981319 - Sequence 79 from Patent EP1723162.
HI508135 - Sequence 4 from Patent EP2152722.
HV304790 - JP 2009531018-A/357: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305288 - JP 2009531019-A/357: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV954027 - JP 2012518421-A/939: METHODS OF DETECTING LUNG CANCER.
HW119497 - JP 2013046612-A/357: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW589826 - JP 2013121348-A/357: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HZ413630 - JP 2014060993-A/357: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ501841 - JP 2016025853-A/357: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
JA526207 - Sequence 357 from Patent EP2369011.
JA526714 - Sequence 357 from Patent EP2369012.
JA527221 - Sequence 357 from Patent EP2369013.
JA536150 - Sequence 357 from Patent EP2371971.
JA715157 - Sequence 939 from Patent EP2401406.
JA788155 - Sequence 357 from Patent EP2479285.
JA788653 - Sequence 357 from Patent EP2479286.
JA810987 - Sequence 357 from Patent EP2468890.
JA811485 - Sequence 357 from Patent EP2468891.
JA811983 - Sequence 357 from Patent EP2468893.
JA812481 - Sequence 357 from Patent EP2468894.
JA812979 - Sequence 357 from Patent EP2468895.
JA813477 - Sequence 357 from Patent EP2468896.
JA813975 - Sequence 357 from Patent EP2468897.
JA814473 - Sequence 357 from Patent EP2468898.
JA814971 - Sequence 357 from Patent EP2468899.
JA817214 - Sequence 357 from Patent EP2468892.
JA826026 - Sequence 357 from Patent EP2471956.
JA826524 - Sequence 357 from Patent EP2471958.
JB024811 - Sequence 357 from Patent EP2505668.
JB025309 - Sequence 357 from Patent EP2505669.
JB079696 - Sequence 357 from Patent EP2487252.
JB080194 - Sequence 357 from Patent EP2487253.
JB080692 - Sequence 357 from Patent EP2487254.
JB081190 - Sequence 357 from Patent EP2487255.
JB081688 - Sequence 357 from Patent EP2487256.
JB082186 - Sequence 357 from Patent EP2487257.
JB082684 - Sequence 357 from Patent EP2487258.
JB083182 - Sequence 357 from Patent EP2487259.
JB083680 - Sequence 357 from Patent EP2487260.
JB084178 - Sequence 357 from Patent EP2487261.
JB084676 - Sequence 357 from Patent EP2487262.
JB085174 - Sequence 357 from Patent EP2487263.
JB087852 - Sequence 357 from Patent EP2502630.
JB148056 - Sequence 357 from Patent EP2484782.
JB148554 - Sequence 357 from Patent EP2484783.
JB153279 - Sequence 357 from Patent EP2514433.
JB153777 - Sequence 357 from Patent EP2514434.
JB256160 - Sequence 79 from Patent EP2327710.
JB622366 - Sequence 357 from Patent EP2586454.
JB622864 - Sequence 357 from Patent EP2586455.
JC001927 - Sequence 357 from Patent EP2591794.
JD030366 - Sequence 11390 from Patent EP1572962.
FW364246 - Oligonucleotides for modulating target RNA activity.
FW504816 - COMPOSITIONS COMPRISING MIR34 THERAPEUTIC AGENTS FOR TREATING CANCER.
FZ414228 - WO 2011007815-A/118: A method for screening a food which promotes production of milk having immunoregulating effect.
HI508167 - Sequence 36 from Patent EP2152722.
HI965151 - Sequence 436 from Patent WO2010139812.
HI965816 - Sequence 136 from Patent WO2010139811.
HI966682 - Sequence 136 from Patent WO2010139810.
HV444519 - JP 2011515078-A/51: TREATMENT, DIAGNOSTIC, AND METHOD FOR DISCOVERING ANTAGONIST USING SPARC SPECIFIC MIRNAS.
HV543936 - JP 2011217617-A/47: Method for testing fibrosis of chronic liver diseases using miRNAs.
HV595155 - JP 2010539959-A/536: Micromirs.
HV753791 - JP 2012509675-A/29: COMPOSITIONS AND METHODS FOR DETECTING SMALL RNAS, AND USES THEREOF.
HV821756 - JP 2011140513-A/118: An Immunostimulating pharmaceutical composition, and a method for producing the immunostimulating pharmaceutical composition.
HW101912 - JP 2013500034-A/39: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW505311 - JP 2014502606-A/213: MELANOMA TREATMENTS.
HZ074163 - JP 2013535982-A/254: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ083047 - JP 2015513906-A/404: Stem Cell Microparticles.
HZ157712 - JP 2015130862-A/536: Micromirs.
HZ186559 - JP 2015146814-A/308: Oligonucleotides for modulating target RNA activity.
HZ436828 - JP 2015529450-A/404: Stem Cell Microparticles.
HZ480236 - JP 2015535430-A/742: TERMINALLY MODIFIED RNA.
HZ790167 - JP 2016504050-A/1912: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA287357 - Sequence 39 from Patent WO2011015720.
JA401189 - Sequence 436 from Patent WO2011080318.
JA402167 - Sequence 436 from Patent WO2011080315.
JA403174 - Sequence 436 from Patent WO2011080316.
JA405805 - Sequence 436 from Patent EP2336353.
JA426673 - Sequence 6 from Patent WO2011072177.
JA429331 - Sequence 436 from Patent WO2011095623.
JA462540 - Sequence 17 from Patent WO2011070297.
JA667971 - Sequence 50 from Patent WO2011139911.
JA682635 - Sequence 103 from Patent WO2011149354.
JB037925 - Sequence 41 from Patent WO2012107841.
JB149043 - Sequence 118 from Patent EP2455486.
JB387961 - Sequence 2 from Patent WO2012041959.
JB620339 - Sequence 319 from Patent WO2013063544.
JC172032 - Sequence 404 from Patent WO2013150303.
JC244960 - Sequence 588 from Patent WO2012020308.
JC512899 - Sequence 3152 from Patent WO2014113089.
JC572033 - Sequence 47 from Patent EP2759595.
JC572843 - Sequence 404 from Patent WO2014125276.
JC582531 - Sequence 404 from Patent WO2014125277.
JE954227 - Sequence 404 from Patent WO2015052526.
JE955980 - Sequence 404 from Patent WO2015052527.
LF132482 - JP 2016506923-A/47: Composition comprising an encapsulated antagomir.
LF137732 - JP 2016507550-A/404: Method of Producing Microparticles.
LF160404 - JP 2016513950-A/470: Oligomers with improved off-target profile.
LF162697 - JP 2016513095-A/404: Stem Cell Microparticles and miRNA.
LF953449 - JP 2016534103-A/404: Stem Cell Microparticles and miRNA.
LG005794 - KR 1020150004822-A/404: STEM CELL MICROPARTICLES.
LG046506 - KR 1020150023687-A/51: Oligonucleotide-Based Inhibitors Comprising Locked Nucleic Acid Motif.
LG053490 - KR 1020150059168-A/404: STEM CELL MICROPARTICLES.
LG162346 - KR 1020160018451-A/47: Composition comprising an encapsulated antagomir.
LG240729 - KR 1020160035087-A/404: STEM CELL MICROPARTICLES AND MIRNA.
LP726442 - Sequence 136 from Patent EP2883966.
LP769477 - Sequence 4 from Patent EP3294910.
LP818712 - Sequence 136 from Patent EP3296406.
LP938654 - Sequence 136 from Patent EP3184651.
LQ070487 - Sequence 811 from Patent EP2964234.
LQ101336 - Sequence 41 from Patent WO2015101653.
LQ276051 - Sequence 41 from Patent WO2016071729.
LQ278634 - Sequence 173 from Patent WO2016066288.
LQ417677 - Sequence 13 from Patent WO2016125163.
LQ724396 - Sequence 29 from Patent WO2018096084.
LQ840941 - Sequence 51 from Patent EP3354734.
LV470814 - JP 2016534036-A/404: Stem Cell Microparticles and miRNA.
LV746126 - JP 2015521626-A/51: OLIGONUCLEOTIDE-BASED INHIBITORS COMPRISING LOCKED NUCLEIC ACID MOTIF.
LY405220 - KR 1020160117535-A/525: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LZ233916 - JP 2017184756-A/308: Oligonucleotides for modulating target RNA activity.
MA259144 - JP 2017502699-A/41: LUNG CANCER DETERMINATIONS USING MIRNA RATIOS.
MA260459 - JP 2017505623-A/525: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA400817 - JP 2018515097-A/4: Method for Diagnosis and Prognosis of Chronic Heart Failure.
MA643988 - JP 2017113010-A/1912: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731872 - JP 2017140048-A/742: TERMINALLY MODIFIED RNA.
MP015104 - Sequence 307 from Patent WO2019016252.
MS834290 - Sequence 436 from Patent EP3112479.
AY940857 - Homo sapiens microRNA hsa-mir-RG-114 variant 2, complete sequence.
AY940856 - Homo sapiens microRNA hsa-mir-RG-114 variant 1, complete sequence.
MA801042 - JP 2018183181-A/1913: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA801041 - JP 2018183181-A/1912: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MP174435 - Sequence 20 from Patent WO2019058253.
MP129504 - Sequence 404 from Patent EP3470073.
MP162427 - Sequence 404 from Patent WO2019069093.
MA896108 - JP 2017217007-A/51: OLIGONUCLEOTIDE-BASED INHIBITORS COMPRISING LOCKED NUCLEIC ACID MOTIF.
MP280757 - Sequence 177 from Patent WO2019111197.
MP283670 - Sequence 177 from Patent WO2019111198.
MB408329 - WO 2019163900-A/36: Method of analysis and diagnose using RNA modification.

-  Other Names for This Gene
  Alternate Gene Symbols: ENST00000385076.1, ENST00000385076.2, NR_029839, uc001plm.1, uc001plm.2, uc001plm.3, uc001plm.4
UCSC ID: ENST00000385076.3
RefSeq Accession: NR_029839

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.